← Back
$REGN All transactions

REGENERON PHARMACEUTICALS, INC.

M 10b5-1 Plan

$ Value

$617K

Shares

1,638

Price

$377

Filed

Feb 23

Insider

Name

Zoghbi Huda Y

Title

CIK

0001681643

Roles

Director

Transaction Details

Transaction Date

2026-02-19

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,341

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. | Represents volume-weighted average price of sales of 53 shares of Company stock on February 19, 2026 at prices ranging from $778.46 to $778.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. | Represents volume-weighted average price of sales of 208 shares of Company stock on February 19, 2026 at prices ranging from $779.10 to $779.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. | Represents volume-weighted average price of sales of 331 shares of Company stock on February 19, 2026 at prices ranging from $780.06 to $780.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. | Represents volume-weighted average price of sales of 209 shares of Company stock on February 19, 2026 at prices ranging from $781.10 to $781.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. | Represents volume-weighted average price of sales of 298 shares of Company stock on February 19, 2026 at prices ranging from $782.01 to $782.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. | Represents volume-weighted average price of sales of 220 shares of Company stock on February 19, 2026 at prices ranging from $783.00 to $783.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. | Represents volume-weighted average price of sales of 160 shares of Company stock on February 19, 2026 at prices ranging from $784.14 to $784.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. | Represents volume-weighted average price of sales of 56 shares of Company stock on February 19, 2026 at prices ranging from $785.60 to $785.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. | The stock option vested in three equal annual installments, commencing one year after the date of grant.

Filing Info

Accession No.

0001681643-26-000004

Form Type

4

Issuer CIK

0000872589

Zoghbi Huda Y's History

Date Ticker Type Value
2026-02-19 REGN M $617K
2026-02-19 REGN $38K
2026-02-19 REGN $39K
2026-02-19 REGN $41K
2026-02-19 REGN $162K
2026-02-19 REGN $258K
2026-02-19 REGN $163K
2026-02-19 REGN $233K
2026-02-19 REGN $172K
2026-02-19 REGN $126K

Other Insiders at REGN (90d)

Insider Bought Sold Last
RYAN ARTHUR F $234K 2026-04-01
Zoghbi Huda Y $1.3M 2026-02-19
Pitofsky Jason
SVP Controller
$1.6M 2026-02-09